HIV

4.

Additional information on the decision not to approve extensions for HIV and TB grants to Bosnia and Hercegovina

16 Aug 2016
Secretariat is reviewing the impact on nine components that are no longer eligible for funding

In GFO #293, we reported that the Global Fund Board turned down a recommendation to provide additional funding for a TB grant and an HIV grant in Bosnia and Herzegovina. Although to still do now know why the Board decided not to grant the additional funding, we now have additional information on what was being requested and why. As well, we are able to report on the reaction of the principal recipient (PR), UNDP.

8.

Funding approved for shortened HIV grant to Uganda

16 Aug 2016
Funds will be used to purchase additional ARVs

On 3 August 2016, the Board approved additional funding of $37 million to ensure that all essential services for a shortened HIV grant to Uganda can be provided through to 31 December 2017. The money will come from the $700 million which the Fund has identified as being available for portfolio optimization. The Board was acting on recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC).

6.

Tanzania will use its HIV grant extension to cover costs of ARVs through to the end of 2017

16 Aug 2016
About half of Tanzanians living with HIV are now receiving ARVs

As reported in GFO #293, the Board has awarded Tanzania’s shortened HIV grant an extension of $109 million to allow it to continue providing essential HIV services through to the end of 2017. The original grant, totaling $277.5 million had an end date of 31 December 2016.

5.

Board turns down proposal to provide additional funding for grants in Bosnia and Herzegovina

3 Aug 2016
A TB grant and HIV grant are affected

GFO has learned that the Global Fund Board has turned down a recommendation to provide additional funding for a TB grant and an HIV grant in Bosnia and Herzegovina.

There has been no public announcement of the Board decision. Nor has the Global Fund made public any details concerning the amounts involved, the rationale for the recommendation, or the reasons why the recommendation was not approved.

2.

Replenishment round-up: Advocacy efforts intensify

2 Aug 2016
How much will the U.K. pledge after Brexit and the change of government?

The Global Fund’s replenishment campaign received a critical advocacy boost in Durban at the 21st International Congress on AIDS with several high-profile side events and the release of the Global Fund Advocates Network’s (GFAN) Cost of Inaction 2016  Report (see GFO article in this issue).

8.

Donor funding for HIV declines for the first time in five years: report

20 Jul 2016

Funding for HIV from donor governments decreased in 2015, by more than $1 billion, compared to 2014, according to a report just released by the Kaiser Foundation and UNAIDS. The report said that funding declined in 13 of 14 donor governments assessed.

2.

In Uganda, a bill regulating NGOs threatens programs targeting key populations

5 Apr 2016
Some CSOs plan to challenge the bill in court

At the end of January, Ugandan president Yoweri Museveni signed a bill that seeks to regulate NGOs. According to activists, some of its provisions could threaten Global Fund–supported programs targeting key populations.

2.

Despite serious concerns about risk, Global Fund approves $316 million in new funding for TB/HIV grants to Nigeria

17 Dec 2015
Grants are considered critical to maintaining and scaling up existing services
Fund says the standard approach to risk mitigation in Nigeria is not sufficient

The Secretariat is recruiting state-level fund portfolio managers for Nigeria

3.

Prevention materials are still getting through to the “uncontrolled areas” of Eastern Ukraine

16 Dec 2015
Delivery of TB medicines is more problematic
Alliance is working with partner organizations

Operating in difficult and deteriorating conditions, the Alliance for Public Health (formerly the International HIV/AIDS Alliance Ukraine), in cooperation with the Global Fund and the World Health Organization, have managed to deliver a one-year supply of the rapid test kits for HIV, STIs and hepatitis C to the uncontrolled regions of the Donbas area in Eastern Ukraine – i.e. Donetsk and Lugansk.

2.

Survey finds African key populations still largely excluded from decision-making, despite NFM promises

23 Nov 2015
Participation diminishes as countries move through the stages of the application process

According to a new report, cornerstone principals of the new funding model, such as inclusive country dialogue and meaningful participation, have not translated in practice for key populations in sub-Saharan Africa.

Pages

Subscribe to HIV